Table 3. Postoperative events.
| Factors | ≤30 days (%) | >30 days (%ppy) |
|---|---|---|
| Structural valve dysfunction (re-intervention) | 0 | 2 (0.1) |
| Nonstructural valve dysfunction (reoperation) | 9 (1.3) | 5 (0.2) |
| Major bleeding | 3 (0.4) | 5 (0.5) |
| Stroke | 15 (2.1) | 7 (0.3) |
| Transient ischemic attack | 5 (0.7) | 0 |
| Peripheral emboli | 0 | 3 (0.1) |
| Myocardial infarction | 2 (0.3) | 3 (0.1) |
| Valve thrombosis | 0 | 0 |
| Endocarditis | 0 | 9 (0.4) |
| Endocarditis (reoperation) | 0 | 5 (0.5) |
| Acute kidney injury | 17 (2.4) | 0 |
| Extracorporeal membrane oxygenation | 11 (1.6) | 0 |
Overall valve related outcome regarding adverse events [total number and percentages ≤30 days postoperatively and events per patient year (%ppy) >30 days postoperatively] are reported.